Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells-Reference-Cited by-同舟云学术

Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells

Published:2005-02 Issue:2 Volume:218 Page:141-151
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Mertens-Talcott Susanne U.,Percival Susan S.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference59 articles.

1. Scientific basis of biomarkers and benefits of functional foods for reduction of disease risk: cancer;Rafter;Br. J. Nutr.,2002

2. Cancer prevention: epidemiology and experiment;Potter;Cancer Lett.,1997

3. Anticlastogenic, antigenotoxic and apoptotic activity of epigallocatechin gallate: a green tea polyphenol;Roy;Mutat. Res.,2003

4. Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE);Kong;Drug Metab. Rev.,2001

5. Signal transduction pathways: targets for green and black tea polyphenols;Park;J. Biochem. Mol. Biol.,2003

Cited by 229 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Potential of Ellagic Acid in Gastrointestinal Cancer Prevention: Recent Advances and Future Directions;Oncology and Therapy;2024-09-02

2. Therapeutic Applications of Nanoformulated Resveratrol and Quercetin Phytochemicals in Colorectal Cancer—An Updated Review;Pharmaceutics;2024-06-04

3. Bio-beneficial spectrum of Tecoma stans flower extract in vitro for fighting prostate and ovarian cancers with its anti-diabetic and antioxidant activities;BioResources;2024-05-30

4. Synergistic inhibitory actions of resveratrol, epigallocatechin-3-gallate, and diallyl trisulfide against skin cancer cell line A431 through mitochondrial caspase dependent pathway: a combinational drug approach;Medical Oncology;2024-01-27

5. Therapeutic Phytoconstituents-II;Nanotechnology Based Delivery of Phytoconstituents and Cosmeceuticals;2024